| HOME >> BIOLOGY >> TECHNOLOGY |
BASIC EPS $1.55 $1.28 21%
==========================================================================
DILUTED EPS $1.52 $1.26 21%
==========================================================================
WEIGHTED AVERAGE NUMBER OF COMMON
SHARES OUTSTANDING
Basic 629 650
Diluted 641 660
--------------------------------------------------------------------------
ADJUSTED PRE-TAX INCOME (excluding
specified items) $1,259 (3) $1,107 (3) 14%
ADJUSTED NET INCOME (excluding
specified items) $1,018 (3) $880 (3) 16%
ADJUSTED DILUTED EPS (excluding
specified items) $1.59 (3) $1.33 (3) 20%
(1) Cost of goods sold in the first quarter of 2008 included a charge of
$53 million ($45 million, or $0.07 per share, on an after-tax basis)
related to COLLEAGUE infusion pumps.
(2) A restructuring charge of $70 million ($46 million, or $0.07 per
share, on an after-tax basis) in 2007 was primarily for costs and
asset impairments associated with the consolidation of certain
commercial and manufacturing operations outside of the United States.
(3) Refer to page 8 for a description of the adjustments and a
reconciliation to GAAP measures.
Non-GAAP Financial Measures: The non-GAAP financial measures contained
in this press release (pre-tax income, net income and per-share earnings,
excluding certain items) adjust for factors that are unusual or
nonrecurring. Unusual or nonrecurring items can be highly variable,
difficult to predict, and of a size that may substantially impact the
company's reported
'/>"/>
| SOURCE Baxter International Inc. Copyright©2008 PR Newswire. All rights reserved |